The PERSPECTIVE trial has commenced in Europe to evaluate the Smaller-Incision New-Generation Implantable Miniature Telescope (SING IMT) in pseudophakic patients with late-stage age-related macular degeneration (AMD). Conducted across France, Germany, and Italy, the multicenter, randomized study aims to assess safety, visual outcomes, and rehabilitation strategies in this previously underserved patient group. The trial's findings may support future label expansion, potentially broadening access to the SING IMT in CE-referenced countries.
Source: Retinal Physician